Literature DB >> 9813168

Zinc-binding of endostatin is essential for its antiangiogenic activity.

T Boehm1, M S O'reilly, K Keough, J Shiloach, R Shapiro, J Folkman.   

Abstract

Endostatin is a potent angiogenesis inhibitor in vitro and in vivo. We used the yeast Pichia pastoris to express and purify soluble endostatin. It was discovered that metal chelating agents can induce N-terminal degradation of endostatin. We theorized that a metal was removed from endostatin which changed the conformation and allowed a contaminating protease to degrade the N-terminus. Atomic absorption and amino acid analysis of endostatin purified from Pichia pastoris and mammalian cells showed a 1:1 molar ratio of Zn2+ to protein. Ding et al. have shown that histidines 1, 3, 11, and aspartic acid 76 coordinate the Zn2+ atom (1). An H1/3A double, an H11A, and a D76A single mutant of endostatin were not able to regress Lewis lung carcinoma. We conclude that the ability of endostatin to bind Zn2+ is essential for its antiangiogenic activity. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9813168     DOI: 10.1006/bbrc.1998.9617

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Zn2+ mediates high affinity binding of heparin to the αC domain of fibrinogen.

Authors:  James C Fredenburgh; Beverly A Leslie; Alan R Stafford; Teresa Lim; Howard H Chan; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

Review 2.  Decoding the Matrix: Instructive Roles of Proteoglycan Receptors.

Authors:  Thomas Neill; Liliana Schaefer; Renato V Iozzo
Journal:  Biochemistry       Date:  2015-07-22       Impact factor: 3.162

Review 3.  Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers.

Authors:  Chiara Poluzzi; Renato V Iozzo; Liliana Schaefer
Journal:  Adv Drug Deliv Rev       Date:  2015-10-27       Impact factor: 15.470

Review 4.  Anti-angiogenic treatment strategies for malignant brain tumors.

Authors:  M Kirsch; G Schackert; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

Review 5.  Molecular mechanisms of tumor angiogenesis and tumor progression.

Authors:  U Cavallaro; G Christofori
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

6.  Optimal production and in vitro activity of recombinant endostatin from stably transformed Drosophila melanogaster S2 cells.

Authors:  J H Park; K H Chang; J M Lee; Y H Lee; I S Chung
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-01       Impact factor: 2.416

7.  Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding.

Authors:  Z Chang; A Choon; A Friedl
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

8.  Antiangiogenic Gene Therapy in Cancer.

Authors:  L Zhang; Q R Chen; A J Mixson
Journal:  Curr Genomics       Date:  2000       Impact factor: 2.236

Review 9.  Cellular actions and signaling by endostatin.

Authors:  Ramani Ramchandran; S Ananth Karumanchi; Jun-ichi Hanai; Seth L Alper; Vikas P Sukhatme
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2002       Impact factor: 1.807

10.  Toenail zinc level and gastric cancer risk in Cali, Colombia.

Authors:  Francia Ivonne Campos; Chihaya Koriyama; Suminori Akiba; Gabriel Carrasquilla; Mauricio Serra; Edwin Carrascal; Megumi Yamamoto; Atsuhiro Nakano
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-10       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.